PetMed Express (PETS)
(Delayed Data from NSDQ)
$3.90 USD
+0.04 (1.04%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $3.90 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.90 USD
+0.04 (1.04%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $3.90 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth D Momentum B VGM
Zacks News
Alibaba (BABA) Q3 Earnings Lag Estimates, Revenues Grow Y/Y
by Zacks Equity Research
Alibaba Group Holding Limited (BABA) fiscal third-quarter revenues driven by strong momentum in the company's New Retail strategy and expanding cloud business. Higher expenses hurt profits.
Alphabet (GOOGL) Q4 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Alphabet Inc. (GOOGL) delivers strong fourth quarter top line numbers on robust advertising and cloud revenues. However, increased expenditure on new activities impacted profits.
Quest Diagnostics (DGX) Tops Q4 Earnings, 2018 View Strong
by Zacks Equity Research
Quest Diagnostics' (DGX) year-over-year revenue improvement in Q4 came on the back of successful execution of its two-point strategy of accelerating growth and driving operational excellence.
Boston Scientific (BSX) Q4 Earnings In Line, Revenues Top
by Zacks Equity Research
In Q4, Boston Scientific (BSX) registers balanced growth across all business lines and geographies.
Conmed (CNMD) Beats Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Conmed (CNMD) benefits from impressive general surgery performance and enhanced innovation in Q4.
McKesson (MCK) Beats on Q3 Earnings & Revenues, Ups '18 View
by Zacks Equity Research
Strong Performance in Distribution Solutions segment drives McKesson (MCK) in Q3. An impressive FY18 outlook instills investor's optimism.
Baxter (BAX) Beats on Q4 Earnings & Revenues, '18 View Solid
by Zacks Equity Research
Strong performance in the Hospital Products and Renal Products segments drives Baxter (BAX) in Q4.
IDEXX Laboratories (IDXX) Beats on Q4 Earnings and Revenues
by Zacks Equity Research
IDEXX (IDXX) rides high on strength in CAG business in Q4. A raised guidance buoys optimism.
Zacks.com highlights: PetMed Express, SINOPEC Shangai Petrochemical, NVR, Five Below and Gap
by Zacks Equity Research
Zacks.com highlights: PetMed Express, SINOPEC Shangai Petrochemical, NVR, Five Below and Gap
QIAGEN (QGEN) Beats on Q4 Earnings and Revenues, Issues View
by Zacks Equity Research
QIAGEN's (QGEN) year-over-year growth in Q4 revenues is encouraging. Expansion in operating margin buoys optimism.
Why AWS is Important for Amazon's (AMZN) Earnings in Q4
by Zacks Equity Research
Amazon's (AMZN) fourth-quarter 2017 results are likely to benefit from AWS's dominant market position and expanding customer base.
5 DuPont-Tested Stocks for a Winning Portfolio
by Zacks Equity Research
Do you have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
ResMed (RMD) Rides on Product Launches, Robust Global Growth
by Zacks Equity Research
ResMed's (RMD) product launches and strategies to gain traction in the sleep-disordered breathing market. This upside is further likely to drive the stock in the future.
KLA-Tencor (KLAC) Beats Earnings and Revenue Estimates in Q2
by Zacks Equity Research
KLA-Tencor Corporation (KLAC) delivers strong second-quarter results driven by strong demand environment, customer acceptance of key products, growth in China and operational efficiencies.
Lam Research (LRCX) Tops Q2 Earnings & Revenue Estimates
by Zacks Equity Research
Lam Research (LRCX) delivers strong fiscal second-quarter results driven by robust equipment demand, strength in device architecture, process flow and advanced packaging technology inflections.
Teradyne (TER) Beats Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Teradyne Inc. (TER) delivers strong fourth-quarter results driven by robust performance in Semiconductor and System Test Businesses.
Top Ranked Growth Stocks to Buy for January 25th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 25th:
PetMed (PETS) Q3 Earnings Top Estimates, Reorder Sales Solid
by Zacks Equity Research
The upside in third-quarter fiscal 2018 sales at PetMed (PETS) is a result of the significant increase in new orders and reorder sales.
Groupon (GRPN) Looks Good: Stock Adds 9% in Session
by Zacks Equity Research
Groupon (GRPN) was a big mover last session, as the company saw its shares rise 9% on Friday amid huge volumes.
Taiwan Semi (TSM) Q4 Earnings Beat on Strong Product Ramp Up
by Zacks Equity Research
Taiwan Semiconductor (TSM) fourth-quarter earnings surpass the Zacks Consensus Estimate on the back of solid performances by mobile products and strong demand from cryptocurrency miners.
JD.com Invests in Tiki.vn, Boosts Southeast Asia Presence
by Zacks Equity Research
JD.com Inc. (JD) will invest in Vietnamese e-commerce firm Tiki.vn, in a bid to expand its presence in Southeast Asia.
Lam Research Gains as Susquehanna Ups Rating, Target Price
by Zacks Equity Research
Lam Research's (LRCX) rating and target price were raised by Susquehanna Financial Group, based on the company's strength in the semiconductor space and favorable industry outlook.
Factors That Make Beacon Roofing (BECN) a Lucrative Bet Now
by Zacks Equity Research
Beacon Roofing Supply (BECN) stock is likely to continue its industry leading performance thanks to focus on acquisitions and strong sales growth within the three product lines.
The Zacks Analyst Blog Highlights: Wal-Mart Stores, Darden Restaurants, At Home Group, EVINE Live and PetMed Express
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Wal-Mart Stores, Darden Restaurants, At Home Group, EVINE Live and PetMed Express
Zacks.com highlights: Robert Half International, PetMed Express, Five Below, Patrick Industries and American Eagle Outfitters
by Zacks Equity Research
Zacks.com highlights: Robert Half International, PetMed Express, Five Below, Patrick Industries and American Eagle Outfitters